| Literature DB >> 11814801 |
Graham S Poindexter1, Marc A Bruce, Karen L LeBoulluec, Ivo Monkovic, Scott W Martin, Eric M Parker, Larry G Iben, Rachel T McGovern, Astrid A Ortiz, Jennifer A Stanley, Gail K Mattson, Michael Kozlowski, Meredith Arcuri, Ildiko Antal-Zimanyi.
Abstract
Dihydropyridine 5a was found to be an inhibitor of neuropeptide Y(1) binding in a high throughput (125)I-PYY screening assay. Structure-activity studies around certain portions of the dihydropyridine chemotype identified BMS-193885 (6e) as a potent and selective Y(1) receptor antagonist. In a forskolin-stimulated c-AMP production assay using CHO cells expressing the human Y(1) receptor, 6e demonstrated full functional antagonism (K(b)=4.5 nM). Compound 6e inhibited NPY-induced feeding in satiated rats when dosed at 3.0 and 10.0 mg/kg (ip), and also decreased spontaneous overnight food consumption in rats at doses of 10 and 20 mg/kg (ip).Entities:
Mesh:
Substances:
Year: 2002 PMID: 11814801 DOI: 10.1016/s0960-894x(01)00761-2
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823